pre-seed
Stage
About
NanoGhost develops a targeted drug delivery platform derived from mesenchymal stem cell membranes that selectively penetrates tumors and inflammatory sites to deliver therapeutics, aiming to improve cancer and inflammation treatments.
Explore NanoGhost's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.